Best Practice & Research Clinical Rheumatology
Volume 20, Issue 4 , Pages 623-625 , August 2006

Preface

References 

  1. Hobbs, Frank and Nicole Stoops, U.S. Census Bureau, Census 2000 Special Reports, Series CENSR-4, Demographic Trends in the 20th Century, U.S. Government Printing Office, Washington, DC, 2002, pp. 58–60.
  2. Wolfe F. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. The Journal of Rheumatology. 2003;30:36–40
  3. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. American Journal of Epidemiology. 1997 Mar 1;145(5):408–415
  4. Sokka T, Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology Criteria for remission. The Journal of Rheumatology. 2003 Jun;30(6):1138–1146
  5. Van Vollenhoven RF, Klareskog L. Clinical responses to tumor necrosis factor α antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor α followup registry. Arthritis and Rheumatism. 2003;48:1500–1503
  6. Gomez-Reino JJ, Carmona L, Valverde VR, et al. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis and Rheumatism. 2003 Aug;48(8):2122–2127
  7. Feltelius N, Fored M, Blomqvist P, et al. Results from a nationwide post marketing cohort study of patients in Sweden treated with etanercept. Annals of the Rheumatic Diseases. 2005 Feb;64(2):246–252
  8. Gibofsky A, Palmer WR, Goldman JA, et al. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study. Current Medical Research and Opinion. 2006 Jan;22(1):169–183
  9. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet. 2004 Jul 17–23;364(9430):263–269

PII: S1521-6942(06)00056-8

doi: 10.1016/j.berh.2006.05.008

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 4 , Pages 623-625 , August 2006

Article Tools